Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 1.2.2016 | EN | Official Journal of the European Union | C 38/58 |

---

Order of the General Court of 2 December 2015 — Novartis v OHIM– Mabxience (HERTIXAN)

(Case T-41/15)[(1)](#ntr1-C_2016038EN.01005801-E0001)

((Community trade mark - Opposition proceedings - Withdrawal of application for registration - No need to adjudicate))

(2016/C 038/77)

Language of the case: Spanish

Parties

Applicant: Novartis AG (Basel, Switzerland) (represented by: M. Douglas, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (represented by: S. Palmero Cabezas, Agent)

Other party to the proceedings before the Board of Appeal of OHIM: Mabxience SA (Montevideo, Uruguay)

Re:

Action brought against the decision of the First Board of Appeal of OHIM of 31 October 2014 (Case R 2550/2013-1) relating to opposition proceedings between Novartis AG and Mabxience SA.

Operative part of the order

|  |  |
| --- | --- |
| 1. | There is no need to adjudicate on the action. |

|  |  |
| --- | --- |
| 2. | Novartis AG is ordered to pay the costs. |

---

[Top](#document1)